
    
      -  Experimental design: multi-center, randomized (1:1), observer-blind, active-controlled
           study in 2 parallel groups with approximately:

        -  Study vaccine: full dose of Fluarix by IM administration.

        -  Control vaccine: full dose of Fluzone by IM administration.

        -  Two scheduled visits per subject at days 0 (visit 1) and 21(visit 2) with blood sample
           collected at each visit to evaluate the immune response. There will be a final contact
           with each subject 6 months after vaccination for safety follow up and study conclusion.

        -  Vaccination schedule: one IM injection at day 0.

        -  Type of study: Self contained.
    
  